Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

128 Results

Guidelines and Advice

Hyperbaric Oxygen Therapy for the Treatment and Prevention of Radionecrosis and Other Radiation-Induced Injuries in Cancer Patients

Status: Archived
ID: HBOT

Jul 2013

Guidelines and Advice

Interferon-alfa in the Treatment of Patients with Inoperable Locally Advanced or Metastatic Renal Cell Cancer

Status: Archived
ID: 3-8-1

Apr 2013

Guidelines and Advice

Adjuvant Radiotherapy in Women with Stage I Endometrial Cancer

Status: Archived
ID: 4-10

Aug 2013

Guidelines and Advice

The Role of Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Excluding Nasopharynx)

Status: Archived
ID: 5-1

Apr 2013

Guidelines and Advice

Treatment of Chronic Myeloid Leukemia with Imatinib

Status: Archived
ID: 6-15

Dec 2013

Guidelines and Advice

Adjuvant Systemic Chemotherapy, Following Surgery and External Beam Radiotherapy, for Adults with Newly Diagnosed Malignant Glioma

Status: Archived
ID: 9-2

Nov 2013

Guidelines and Advice

Ibritumomab Tiuxetan in Lymphoma

Status: Archived
ID: 6-17

Nov 2013

Guidelines and Advice

Treatment with Fludarabine for Patients with Follicular and Other Low Grade Non-Hodgkin's Lymphoma and Waldenstrom's Macroglobulinemia

Status: Archived
ID: 6-2
Version: 2

Aug 2013

Guidelines and Advice

Gliadel Wafers in the Treatment of Malignant Glioma

Status: Archived
ID: 9-7

Mar 2013

Guidelines and Advice

Liposomal Anthracyclines in the Management of HIV-positive Kaposi's Sarcoma

Status: Archived
ID: 12-8
Version: 2

Jun 2013

Statistical Reports

Cancer Risk Factors in Ontario: Evidence Summary

Mar 2013

Regimen

ALDE(Intralesional)

Cancer Type:

Skin,

Melanoma

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative, Curative

Funding:

New Drug Funding Program

Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

May 2019

Pages